意大利肾移植后妊娠结局:随时间的变化是不同治疗方案还是不同策略的结果?一项全国性调查(1978-2013)
该全国性调查纳入意大利1978-2013年间222例肾移植后活产妊娠,按2000年1月前后分两组,并与1418例低风险妊娠对照。随时间推移,早期早产率从13.4%升至27.1%(P=0.049),小于第5百分位婴儿从22.2%降至9.6%(P=0.036),移植受者不良结局风险显著高于对照。
要点
- 肾移植后妊娠早产率57.3%、早期早产22.2%、小于胎龄儿14%,均显著高于低风险对照(P<0.001)。
- 2000年后早期早产率较前升高(13.4%升至27.1%,P=0.049),小于第5百分位婴儿比例下降(22.2%降至9.6%,P=0.036)。
- 多数患者肾功能至产后6个月保持稳定,2000年后无新生儿死亡。
核心结论
- 移植后妊娠不良结局风险高于一般人群,随时间小于胎龄儿发生率下降而早期早产发生率增加。
- 尽管承认治疗(环孢素与他克莫司)和母亲年龄(显著增加)的差异,小于胎龄儿减少和早产增加可能由倾向于早期分娩以应对胎儿生长受限风险的产科策略解释。
研究设计与样本
- 全国性调查,涉及意大利所有移植中心,收集各中心自开始活动以来记录的所有妊娠,估计全国覆盖率75%。
- 数据库包含移植后活产妊娠222例(2000年前83例,2000-13年139例;分别有68例和121例具备基线和出生数据),以及低风险对照1418例(来自意大利两个大型中心2000-14年都灵和卡利亚里观察研究队列)。
- 记录并回顾终末期肾病病因、透析、活体/尸体肾移植、药物治疗、合并症及主要母胎结局数据。
主要发现
- 患者年龄随时间显著增加(1978-99年30.7±3.7岁 vs 2000-13年34.1±3.7岁;P<0.001)。
- 早期早产儿患病率从第一时期的13.4%增加至第二时期的27.1%(P=0.049),晚期早产儿非显著下降(38.8% vs 33.1%),所有早产儿患病率几乎不变(52.2% vs 60.2%;P=0.372)。
- 小于第5百分位婴儿随时间减少(22.2% vs 9.6%;P=0.036)。
- 与对照相比,所有移植病例早产57.3% vs 6.3%、早期早产22.2% vs 0.9%、小于胎龄儿14% vs 4.5%(P<0.001);仅肾功能正常的移植患者早产35% vs 6.3%、早期早产10% vs 0.9%、小于胎龄儿23.7% vs 4.5%(P<0.001),风险随CKD分期增加。
- 多数患者肾功能至产后6个月保持稳定;2000年后无新生儿死亡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Kidney transplantation is the treatment of choice to restore fertility to women on renal replacement therapy. Over time, immunosuppressive, support therapies and approaches towards high-risk pregnancies have changed. The aim of this study was to analyse maternal-foetal outcomes in two cohorts of transplanted women who delivered a live-born baby in Italy in 1978-2013, dichotomized into delivery before and after January 2000. METHODS: A survey involving all the Italian transplant centres was carried out, gathering data on all pregnancies recorded since the start of activity at each centre; the estimated nationwide coverage was 75%. Data on cause of ESRD, dialysis, living/cadaveric transplantation, drug therapy, comorbidity, and the main maternal-foetal outcomes were recorded and reviewed. Data were compared with a low-risk cohort of pregnancies from two large Italian centres (2000-14; Torino and Cagliari Observational Study cohort). RESULTS: The database consists of 222 pregnancies with live-born babies after transplantation (83 before 2000 and 139 in 2000-13; 68 and 121 with baseline and birth data, respectively), and 1418 low-risk controls. The age of the patients significantly increased over time (1978-99: age 30.7 ± 3.7 versus 34.1 ± 3.7 in 2000-13; P < 0.001). Azathioprine, steroids and cyclosporine A were the main drugs employed in the first time period, while tacrolimus emerged in the second. The prevalence of early preterm babies increased from 13.4% in the first to 27.1% in the second period (P = 0.049), while late-preterm babies non-significantly decreased (38.8 versus 33.1%), thus leaving the prevalence of all preterm babies almost unchanged (52.2 and 60.2%; P = 0.372). Babies below the 5th percentile decreased over time (22.2 versus 9.6%; P = 0.036). In spite of high prematurity rates, no neonatal deaths occurred after 2000. The results in kidney transplant patients are significantly different from controls both considering all cases [preterm delivery: 57.3 versus 6.3%; early preterm: 22.2 versus 0.9%; small for gestational age (SGA): 14 versus 4.5%; P < 0.001] and considering only transplant patients with normal kidney function [preterm delivery: 35 versus 6.3%; early preterm: 10 versus 0.9%; SGA: 23.7 versus 4.5% (P < 0.001); risks increase across CKD stages]. Kidney function remained stable in most of the patients up to 6 months after delivery. Multiple regression analysis performed on the transplant cohort highlights a higher risk of preterm delivery in later CKD stages, an increase in preterm delivery and a decrease in SGA across periods. CONCLUSIONS: Pregnancy after transplantation has a higher risk of adverse outcomes compared with the general population. Over time, the incidence of SGA babies decreased while the incidence of 'early preterm' babies increased. Although acknowledging the differences in therapy (cyclosporine versus tacrolimus) and in maternal age (significantly increased), the decrease in SGA and the increase in prematurity may be explained by an obstetric policy favouring earlier delivery against the risk of foetal growth restriction.
引用
- Piccoli GB, Cabiddu G, Attini R, et al. Pregnancy outcomes after kidney graft in Italy: are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013). Nephrol Dial Transplant. 2016. PMID: 27604074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。